Literature DB >> 21956053

Use of positron emission tomography to detect infection around antibiotic-loaded cement spacers in patients with high C-reactive protein levels.

Ming-Jhe Huang1, Pang-Hsin Hsieh, Steve W N Ueng, Kung-Chu Ho, Tzu-Chen Yen, Mel S Lee.   

Abstract

In patients who have antibiotic-loaded cement hip spacers in the interim period, the correct diagnosis of infection eradication is the major determinant before reimplantation arthroplasty. Diagnosis is usually based on clinical findings and serum C-reactive protein (CRP) levels. However, diagnosis can be challenging when the clinical findings are normal but the CRP level is high. From March 2007 to January 2008, fluorodeoxy-glucose positron emission tomography (FDG-PET) was used to detect infection around antibiotic-loaded cement spacers in 13 patients (mean age, 60 years). Although patients' clinical conditions were deemed suitable for reimplantation, their serum CRP levels were persistently elevated (mean, 54 mg/L) an average of 120 days (range, 28-413 days) after the first-stage operation. Reimplantation total hip arthroplasty (THA) was subsequently performed in 7 patients based on the negative findings of FDG-PET. In 6 patients, FDG-PET was positive for infection. The persistence of infection was confirmed in 3 of these patients by another debridement surgery. Staged reimplantation THA was delayed in 1 patient who underwent repeat debridement and in 3 patients who were treated with extended periods of oral antibiotics. Of the 11 staged reimplantation THAs, only 1 reinfection was noted at an average follow-up of 48 months. The success rate of 91% suggests FDG-PET could help in the differential diagnosis of infection around cement spacers, especially in patients with normal clinical findings but elevated CRP levels. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956053     DOI: 10.3928/01477447-20110826-08

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

1.  What Markers Best Guide the Timing of Reimplantation in Two-stage Exchange Arthroplasty for PJI? A Systematic Review and Meta-analysis.

Authors:  Yong Seuk Lee; Navin Fernando; Kyung-Hoi Koo; Hyun Jung Kim; Hamed Vahedi; Antonia F Chen
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

2.  Detecting the Presence of Bacterial DNA and RNA by Polymerase Chain Reaction to Diagnose Suspected Periprosthetic Joint Infection after Antibiotic Therapy.

Authors:  Xin-Yu Fang; Wen-Bo Li; Chao-Fan Zhang; Zi-da Huang; Hui-Yi Zeng; Zheng Dong; Wen-Ming Zhang
Journal:  Orthop Surg       Date:  2018-01-30       Impact factor: 2.071

3.  Diagnostic value of triple-phase bone scintigraphy for the diagnosis of infection around antibiotic-impregnated cement spacers.

Authors:  Masahiko Ikeuchi; Yusuke Okanoue; Masashi Izumi; Goichi Fukuda; Koji Aso; Natsuki Sugimura; Teruhiko Kawakami; Toshikazu Tani
Journal:  Springerplus       Date:  2013-08-27

4.  Molecular diagnosis of periprosthetic joint infection by quantitative RT-PCR of bacterial 16S ribosomal RNA.

Authors:  Mel S Lee; Wen-Hsin Chang; Su-Chin Chen; Pang-Hsin Hsieh; Hsin-Nung Shih; Steve W N Ueng; Gwo-Bin Lee
Journal:  ScientificWorldJournal       Date:  2013-12-17

Review 5.  Two-Stage Reimplantation in Infected Total Knee Arthroplasty.

Authors:  Yong Seuk Lee; Antonia F Chen
Journal:  Knee Surg Relat Res       Date:  2018-06-01

6.  The potential performance of serum albumin to globulin ratio, albumin and globulin in the diagnosis of periprosthetic joint infection and prediction of reinfection following reimplantation.

Authors:  Haitao Zhang; Shuihua Xie; YiJin Li; Jiahao Li; Peng Deng; Huiliang Zeng; Houran Cao; Min Liu; Jie Li; Wenjun Feng; Pengcheng Ye; Yingjie Ge; Jianchun Zeng; Yirong Zeng
Journal:  BMC Musculoskelet Disord       Date:  2022-07-30       Impact factor: 2.562

7.  Sonication of antibiotic-loaded cement spacers in a two-stage revision protocol for infected joint arthroplasty.

Authors:  Massimo Mariconda; Tiziana Ascione; Giovanni Balato; Renato Rotondo; Francesco Smeraglia; Giovan Giuseppe Costa; Marco Conte
Journal:  BMC Musculoskelet Disord       Date:  2013-06-24       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.